Amplifon’s Acquisition Announcement#
Amplifon SpA, an Italian retailer specializing in hearing aids, recently announced a surprising acquisition of GN Hearing for €2.3 billion. This announcement has caused Amplifon’s shares to fall to their lowest level since late 2016, trading at €8.02, down from €10.52 prior to the announcement.
Details of the Deal#
The acquisition involves Amplifon paying GN Store Nord €1.69 billion in cash, financed through a combination of debt and an equity raise. Specifically, Amplifon plans to raise up to €0.75 billion in equity and issue 56 million new shares, giving GN a 16% stake in the larger company. The deal does not require shareholder approval unless the equity raise exceeds 20% of Amplifon’s share capital. The closing of the deal is expected by the end of 2026, pending regulatory approvals.
Analyst Reactions#
Following the announcement, both Barclays and Jefferies downgraded their ratings on Amplifon. Barclays reduced its price target by 38% to €10, stating that the acquisition represents a significant strategic shift for Amplifon, which had previously focused solely on retail. Jefferies cut its price target by 50% to €8, expressing concerns about the potential dilution of shares due to the new equity issuance and the likelihood of GN selling its stake in the near future.
Implications for the Market#
The acquisition is expected to create synergies of €60 million to €80 million by the end of 2029, primarily through increased volume production. However, analysts from both banks noted that the deal could negatively impact competitors like Sonova and Demant, which have previously accounted for a significant portion of Amplifon’s sales. Meanwhile, shares of GN Store Nord rose significantly following the announcement, reflecting positive market sentiment towards the deal.